|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
1 | AN ACT concerning regulation.
| ||||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||||
4 | Section 5. The Pharmacy Practice Act of 1987 is amended by | ||||||||||||||||||||||||||
5 | changing Section 3 and by adding Section 41 as follows:
| ||||||||||||||||||||||||||
6 | (225 ILCS 85/3) (from Ch. 111, par. 4123)
| ||||||||||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2008)
| ||||||||||||||||||||||||||
8 | Sec. 3. Definitions. For the purpose of this Act, except | ||||||||||||||||||||||||||
9 | where otherwise
limited therein:
| ||||||||||||||||||||||||||
10 | (a) "Pharmacy" or "drugstore" means and includes every | ||||||||||||||||||||||||||
11 | store, shop,
pharmacy department, or other place where | ||||||||||||||||||||||||||
12 | pharmaceutical care is
provided
by a pharmacist (1) where | ||||||||||||||||||||||||||
13 | drugs, medicines, or poisons are
dispensed, sold or
offered for | ||||||||||||||||||||||||||
14 | sale at retail, or displayed for sale at retail; or
(2)
where
| ||||||||||||||||||||||||||
15 | prescriptions of physicians, dentists, veterinarians, | ||||||||||||||||||||||||||
16 | podiatrists, or
therapeutically certified optometrists, within | ||||||||||||||||||||||||||
17 | the limits of their
licenses, are
compounded, filled, or | ||||||||||||||||||||||||||
18 | dispensed; or (3) which has upon it or
displayed within
it, or | ||||||||||||||||||||||||||
19 | affixed to or used in connection with it, a sign bearing the | ||||||||||||||||||||||||||
20 | word or
words "Pharmacist", "Druggist", "Pharmacy", | ||||||||||||||||||||||||||
21 | "Pharmaceutical
Care", "Apothecary", "Drugstore",
"Medicine | ||||||||||||||||||||||||||
22 | Store", "Prescriptions", "Drugs", "Medicines", or any word
or | ||||||||||||||||||||||||||
23 | words of similar or like import, either in the English language
| ||||||||||||||||||||||||||
24 | or any other language; or (4) where the characteristic | ||||||||||||||||||||||||||
25 | prescription
sign (Rx) or similar design is exhibited; or (5) | ||||||||||||||||||||||||||
26 | any store, or
shop,
or other place with respect to which any of | ||||||||||||||||||||||||||
27 | the above words, objects,
signs or designs are used in any | ||||||||||||||||||||||||||
28 | advertisement.
| ||||||||||||||||||||||||||
29 | (b) "Drugs" means and includes (l) articles recognized
in | ||||||||||||||||||||||||||
30 | the official United States Pharmacopoeia/National Formulary | ||||||||||||||||||||||||||
31 | (USP/NF),
or any supplement thereto and being intended for and | ||||||||||||||||||||||||||
32 | having for their
main use the diagnosis, cure, mitigation, |
| |||||||
| |||||||
1 | treatment or prevention of
disease in man or other animals, as | ||||||
2 | approved by the United States Food and
Drug Administration, but | ||||||
3 | does not include devices or their components, parts,
or | ||||||
4 | accessories; and (2) all other articles intended
for and having | ||||||
5 | for their main use the diagnosis, cure, mitigation,
treatment | ||||||
6 | or prevention of disease in man or other animals, as approved
| ||||||
7 | by the United States Food and Drug Administration, but does not | ||||||
8 | include
devices or their components, parts, or accessories; and | ||||||
9 | (3) articles
(other than food) having for their main use and | ||||||
10 | intended
to affect the structure or any function of the body of | ||||||
11 | man or other
animals; and (4) articles having for their main | ||||||
12 | use and intended
for use as a component or any articles | ||||||
13 | specified in clause (l), (2)
or (3); but does not include | ||||||
14 | devices or their components, parts or
accessories.
| ||||||
15 | (c) "Medicines" means and includes all drugs intended for
| ||||||
16 | human or veterinary use approved by the United States Food and | ||||||
17 | Drug
Administration.
| ||||||
18 | (d) "Practice of pharmacy" means the provision of | ||||||
19 | pharmaceutical care to
patients as determined by the | ||||||
20 | pharmacist's professional judgment in the
following areas,
| ||||||
21 | which may include but are not limited to (1) patient
| ||||||
22 | counseling, (2)
interpretation and assisting in the monitoring | ||||||
23 | of appropriate drug use and
prospective drug utilization | ||||||
24 | review, (3) providing information on the
therapeutic values, | ||||||
25 | reactions, drug interactions, side effects, uses, selection
of | ||||||
26 | medications and medical devices, and outcome of drug therapy, | ||||||
27 | (4)
participation in drug selection, drug monitoring, drug | ||||||
28 | utilization review,
evaluation, administration, | ||||||
29 | interpretation, application of
pharmacokinetic and
laboratory | ||||||
30 | data to design safe and effective drug
regimens, (5) drug | ||||||
31 | research
(clinical and scientific), and (6) compounding and | ||||||
32 | dispensing of drugs and medical
devices.
| ||||||
33 | (e) "Prescription" means and includes any written, oral, | ||||||
34 | facsimile, or
electronically transmitted order for drugs
or | ||||||
35 | medical devices, issued by a physician licensed to practice | ||||||
36 | medicine in
all its branches, dentist, veterinarian, or |
| |||||||
| |||||||
1 | podiatrist, or therapeutically
certified
optometrist, within | ||||||
2 | the
limits of their licenses, by a physician assistant in | ||||||
3 | accordance with
subsection (f) of Section 4, or by an advanced | ||||||
4 | practice nurse in
accordance with subsection (g) of Section 4, | ||||||
5 | containing the
following: (l) name
of the patient; (2) date | ||||||
6 | when prescription was issued; (3) name
and strength of drug or | ||||||
7 | description of the medical device prescribed;
and (4) quantity, | ||||||
8 | (5) directions for use, (6) prescriber's name,
address
and | ||||||
9 | signature, and (7) DEA number where required, for controlled
| ||||||
10 | substances.
DEA numbers shall not be required on inpatient drug | ||||||
11 | orders.
| ||||||
12 | (f) "Person" means and includes a natural person, | ||||||
13 | copartnership,
association, corporation, government entity, or | ||||||
14 | any other legal
entity.
| ||||||
15 | (g) "Department" means the Department of Professional | ||||||
16 | Regulation.
| ||||||
17 | (h) "Board of Pharmacy" or "Board" means the State Board
of | ||||||
18 | Pharmacy of the Department of Professional Regulation.
| ||||||
19 | (i) "Director" means the Director of Professional | ||||||
20 | Regulation.
| ||||||
21 | (j) "Drug product selection" means the interchange for a
| ||||||
22 | prescribed pharmaceutical product in accordance with Section | ||||||
23 | 25 of
this Act and Section 3.14 of the Illinois Food, Drug and | ||||||
24 | Cosmetic Act.
| ||||||
25 | (k) "Inpatient drug order" means an order issued by an | ||||||
26 | authorized
prescriber for a resident or patient of a facility | ||||||
27 | licensed under the
Nursing Home Care Act or the Hospital | ||||||
28 | Licensing Act, or "An Act in relation to
the founding and | ||||||
29 | operation of the University of Illinois Hospital and the
| ||||||
30 | conduct of University of Illinois health care programs", | ||||||
31 | approved July 3, 1931,
as amended, or a facility which is | ||||||
32 | operated by the Department of Human
Services (as successor to | ||||||
33 | the Department of Mental Health
and Developmental | ||||||
34 | Disabilities) or the Department of Corrections.
| ||||||
35 | (k-5) "Pharmacist" means an individual health care | ||||||
36 | professional and
provider currently licensed by this State to |
| |||||||
| |||||||
1 | engage in the practice of
pharmacy.
| ||||||
2 | (l) "Pharmacist in charge" means the licensed pharmacist | ||||||
3 | whose name appears
on a pharmacy license and who is responsible | ||||||
4 | for all aspects of the
operation related to the practice of | ||||||
5 | pharmacy.
| ||||||
6 | (m) "Dispense" means the delivery of drugs and medical | ||||||
7 | devices, in
accordance with applicable State and federal laws | ||||||
8 | and regulations, to the
patient or the patient's representative | ||||||
9 | authorized to receive these products,
including the | ||||||
10 | preparation, compounding, packaging, and labeling necessary | ||||||
11 | for delivery, computer entry, and verification of medication | ||||||
12 | orders and prescriptions, and
any recommending or advising | ||||||
13 | concerning the contents and therapeutic values and
uses | ||||||
14 | thereof. "Dispense" does not mean the physical delivery to a | ||||||
15 | patient or a
patient's representative in a home or institution | ||||||
16 | by a designee of a pharmacist
or by common carrier. "Dispense" | ||||||
17 | also does not mean the physical delivery
of a drug or medical | ||||||
18 | device to a patient or patient's representative by a
| ||||||
19 | pharmacist's designee within a pharmacy or drugstore while the | ||||||
20 | pharmacist is
on duty and the pharmacy is open.
| ||||||
21 | (n) "Mail-order pharmacy" means a pharmacy that is located | ||||||
22 | in a state
of the United States, other than Illinois, that | ||||||
23 | delivers, dispenses or
distributes, through the United States | ||||||
24 | Postal Service or other common
carrier, to Illinois residents, | ||||||
25 | any substance which requires a prescription.
| ||||||
26 | (o) "Compounding" means the preparation, mixing, | ||||||
27 | assembling,
packaging, or labeling of a drug or medical device: | ||||||
28 | (1) as the result of a
practitioner's prescription drug order | ||||||
29 | or initiative that is dispensed pursuant
to a prescription in | ||||||
30 | the course of professional practice; or (2) for the
purpose of, | ||||||
31 | or incident to, research, teaching, or chemical analysis; or | ||||||
32 | (3) in anticipation of prescription drug orders
based on | ||||||
33 | routine, regularly observed prescribing patterns.
| ||||||
34 | (p) "Confidential information" means information,
| ||||||
35 | maintained by the
pharmacist in the patient's records, released | ||||||
36 | only (i) to the patient or,
as the patient directs, to other |
| |||||||
| |||||||
1 | practitioners and other pharmacists or (ii)
to any other person | ||||||
2 | authorized by law to receive the
information.
| ||||||
3 | (q) "Prospective drug review" or "drug utilization | ||||||
4 | evaluation" means a
screening for potential drug therapy | ||||||
5 | problems due to
therapeutic duplication, drug-disease | ||||||
6 | contraindications, drug-drug
interactions (including serious | ||||||
7 | interactions with nonprescription or
over-the-counter drugs), | ||||||
8 | drug-food interactions, incorrect drug dosage
or duration of | ||||||
9 | drug
treatment, drug-allergy interactions, and clinical abuse | ||||||
10 | or misuse.
| ||||||
11 | (r) "Patient counseling" means the communication between a | ||||||
12 | pharmacist or
a student pharmacist under the direct supervision | ||||||
13 | of a pharmacist and a
patient or the patient's representative | ||||||
14 | about the patient's medication or
device for the purpose of | ||||||
15 | optimizing proper use of prescription medications
or devices. | ||||||
16 | The offer to counsel by the pharmacist or the pharmacist's
| ||||||
17 | designee, and subsequent patient counseling by the pharmacist | ||||||
18 | or student
pharmacist, shall be made in a face-to-face | ||||||
19 | communication with the patient
or patient's representative | ||||||
20 | unless, in the professional judgment of the
pharmacist, a | ||||||
21 | face-to-face communication is deemed inappropriate or
| ||||||
22 | unnecessary. In that instance, the offer to counsel or patient | ||||||
23 | counseling may
be made in a written communication, by | ||||||
24 | telephone, or in a manner determined by
the pharmacist to be | ||||||
25 | appropriate.
| ||||||
26 | (s) "Patient profiles" or "patient drug therapy record" | ||||||
27 | means the
obtaining, recording, and maintenance of patient | ||||||
28 | prescription
information, including prescriptions for | ||||||
29 | controlled substances, and
personal information.
| ||||||
30 | (t) "Pharmaceutical care" includes, but is not limited to, | ||||||
31 | the act of
monitoring drug use and other patient care services | ||||||
32 | intended to achieve
outcomes that improve the patient's quality | ||||||
33 | of life but shall not include
the sale of over-the-counter | ||||||
34 | drugs by a seller of goods and services who
does not dispense | ||||||
35 | prescription drugs.
| ||||||
36 | (u) "Medical device" means an instrument, apparatus, |
| |||||||
| |||||||
1 | implement, machine,
contrivance, implant, in vitro reagent, or | ||||||
2 | other similar or related article,
including any component part | ||||||
3 | or accessory, required under federal law to
bear the label | ||||||
4 | "Caution: Federal law requires dispensing by or on the order
of | ||||||
5 | a physician". A seller of goods and services who, only for the | ||||||
6 | purpose of
retail sales, compounds, sells, rents, or leases | ||||||
7 | medical devices shall not,
by reasons thereof, be required to | ||||||
8 | be a licensed pharmacy.
| ||||||
9 | (v) "Unique identifier" means an electronic signature, | ||||||
10 | handwritten
signature or initials, thumb print, or other | ||||||
11 | acceptable individual biometric
or electronic identification | ||||||
12 | process as approved by the Department.
| ||||||
13 | (w) "Current retail price" means the actual price that a | ||||||
14 | pharmacy charges a retail purchaser.
| ||||||
15 | (Source: P.A. 92-880, eff. 1-1-04; 93-571, eff. 8-20-03; | ||||||
16 | 93-1075, eff. 1-18-05.)
| ||||||
17 | (225 ILCS 85/41 new) | ||||||
18 | Sec. 41. Current retail price disclosure. Upon a request | ||||||
19 | made in person, in writing, or
by telephone by any person, a | ||||||
20 | pharmacist must disclose the current retail price of any brand | ||||||
21 | or generic prescription drug or medical device that the | ||||||
22 | pharmacy offers for sale to the public.
|